Joint Clinical Assessments in Europe: Implications for Market Access, Reimbursement, and National HTA Alignment
{{output}}
The Joint Clinical Assessment is a crucial development under the European Union Health Technology Assessment Regulation (EU HTAR, 2021/2282), aimed at standardizing clinical assessments across the Member States. This review explores the opportunities, challeng... ...